|
|
.
See Category: Neoplasms
ICD-10 (CM) Code and Descriptor
|
D30.4 |
Benign neoplasm of urethra
|
D304 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 14 |
| 37.58%
|
30.57%
|
14.01%
|
5.73%
|
5.10%
|
1.27%
|
2.55%
|
1.27%
|
1.27%
|
0.64%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D30.4*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
35
|
40
|
|
J3010
|
FENTANYL CITRATE INJECTION |
30
|
32
|
|
J2405
|
ONDANSETRON HCL INJECTION |
27
|
108
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
27
|
609
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
20
|
73
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
17
|
100
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
17
|
18
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
17
|
41
|
|
J7120
|
RINGERS LACTATE INFUSION |
16
|
22
|
|
52204
|
CYSTOSCOPY W/BIOPSY(S) |
14
|
14
|
|
88112
|
CYTOPATH CELL ENHANCE TECH |
10
|
11
|
|
C1758
|
CATHETER, URETERAL |
9
|
9
|
|
80048
|
METABOLIC PANEL TOTAL CA |
9
|
9
|
|
J2001
|
LIDOCAINE INJECTION |
8
|
53
|
|
J1170
|
HYDROMORPHONE INJECTION |
8
|
10
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
7
|
7
|
|
82962
|
GLUCOSE BLOOD TEST |
7
|
10
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
7
|
81
|
|
C1769
|
GUIDE WIRE |
7
|
9
|
|
85027
|
COMPLETE CBC AUTOMATED |
7
|
7
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D30.4 related to the following DRG Codes:
656-658
686-688
|
